New to Magnet.me? Sign up now to get your own personalised job matches.

Sign up
Logo Calypso Biotech

Calypso Biotech

Calypso Biotech’s portfolio consists of two preclinical therapeutic antibodies that intercept key immune checkpoints involved in multiple immune pathologies.
Calypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and neutralizes interleukin-15 (IL-15). IL-15 plays multiple roles in the immune system by controlling the homeostasis and activation of T, B, NK but also has recently emerged as a...

Pharmaceutical
Amsterdam, NL
25 employees

Calypso Biotech

Calypso Biotech’s portfolio consists of two preclinical therapeutic antibodies that intercept key immune checkpoints involved in multiple immune pathologies.
Calypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and neutralizes interleukin-15 (IL-15). IL-15 plays multiple roles in the immune system by controlling the homeostasis and activation of T, B, NK but also has recently emerged as a...

Pharmaceutical
Amsterdam, NL
25 employees
Share:
Share:

Find your job or internship faster with a profile.

Sign up now and directly see which opportunities match your preferences.

Opportunities

There are currently no open opportunities at Calypso Biotech. Please check again later.

Interesting to know

This company page was generated automatically and therefore features only limited information. Find out more about Calypso Biotech on their company website:

Logo Calypso Biotech

Interested in working at Calypso Biotech?

When you connect, your chance of being approached for an opportunity at this company is 3 times higher.